Does Eating Burnt Food Cause Cancer?

The burnt edge of a roast potato, the dark corner of a slice of toast, the charred bit on a sausage: all three contain compounds that regulators treat as a cancer risk, and the advice to avoid them is now two decades old. What almost nobody says out loud is that the large human studies behind the headlines never measured how burnt anyone's food was. They measured something else, and the gap between the two is the whole story.

TL;DR

• Acrylamide forms when starchy foods are cooked above 120°C and has been classed as probably carcinogenic to humans since 1994, on animal evidence. IARC's advisory groups recommended reconsidering that in 2019 and again in 2024, but recommending a re-examination is not conducting one.
• The largest synthesis found nothing. Across 16 studies, 1,151,189 people and 48,175 cancers, higher estimated acrylamide intake was not associated with any site-specific cancer outside the gynaecological ones.
• Exposure came from food questionnaires in every one of those studies. A questionnaire records that you ate toast, not how dark it was.
• One large cohort is the exception. In 80,597 French women, the highest quarter of acrylamide intake carried a 40% higher risk of premenopausal breast cancer, though the dose-response was not orderly.
• Biomarker data from 2024 complicates the picture. Vegans carried more acrylamide in their blood than omnivores, and people who had eaten nothing heated for four months still carried about half the omnivore level.
• One piece of the practical advice has been withdrawn. The Food Standards Agency still says aim for golden yellow or lighter, but no longer advises against keeping potatoes in the fridge.

What IARC has decided, and what it hasn't

Acrylamide was found in food in 2002, when Swedish researchers discovered it forming in carbohydrate-rich foods during browning. It had been classified as probably carcinogenic to humans — Group 2A — eight years earlier, on evidence that had little to do with diet. As the epidemiologists Janneke Hogervorst and Leo Schouten put it in 2022, the regulatory measures that followed "were based on animal studies, particularly on 2-year rodent carcinogen assays", a test they note predicts human carcinogenicity poorly.

That 1994 classification still stands, and this is where a good deal of coverage goes wrong, because IARC has since produced documents that look like reassessments and are not. In 2019 its advisory group on priorities listed acrylamide as a high priority for re-evaluation, noting evidence "suggestive of modest associations for cancer of the kidney" and for "cancers of the endometrium and the ovary in never-smokers", and concluding that "an updated evaluation of the newly available evidence in humans may be useful". In November 2024 the next advisory group listed it as high priority again, under the heading of new human and mechanistic evidence warranting re-evaluation.

Both documents recommend which agents IARC should examine over the next five years, and IARC describes them in exactly those terms. Neither evaluates the evidence or issues a classification. The scheduled monograph volumes as of late 2026 cover cannabis smoking and then lead and cadmium, so a re-examination has been recommended for seven years without happening, and the 1994 classification remains the one in force.

What the human studies measured

The most comprehensive synthesis of the human evidence is a dose-response meta-analysis published in 2022, pooling 16 studies: 1,151,189 participants, 48,175 of whom developed cancer over a median 14.9 years. Mean estimated intake was 23 micrograms a day. Comparing the highest intakes with the lowest, there was no association with colorectal cancer (0.94, 95% CI 0.87–1.02), kidney cancer (1.08, 0.93–1.26), prostate cancer (1.00, 0.93–1.07), pancreatic cancer (0.88, 0.77–1.02) or any other site examined, and no threshold in the dose-response modelling.

One result did stand out. Among smokers, higher dietary acrylamide was associated with a 16% higher risk of lung cancer (1.16, 1.03–1.31). That came from two studies, the overall lung analysis was badly heterogeneous, and tobacco smoke is itself a major source of acrylamide — so it reads as a lead rather than a finding.

A companion meta-analysis from 2020 covered the sites the larger one deliberately excluded, and came out null as well: breast cancer 0.96 (0.91–1.02), endometrial 1.03 (0.91–1.17), ovarian 1.01 (0.87–1.18). Among never-smoking women the endometrial and ovarian estimates ran higher, at 1.14 and 1.17, but both crossed one and the authors called their summary estimates statistically imprecise.

Here is the part that matters for the burnt-food question. Every study in both analyses estimated acrylamide exposure from a food frequency questionnaire mapped onto a food composition database. The authors of the larger review state the consequence plainly: their databases could not capture variation between brands of the same food, or "the different cooking methods used at home by the participants". The 2020 review says the questionnaires "did not generally capture cooking methods". These studies tell you something real and useful about estimated dietary acrylamide and cancer incidence in a million people. They do not isolate the effect of burning, because nobody recorded it.

The one cohort that found something

The clearest positive result in the field comes from NutriNet-Santé, a French web-based cohort, published in 2022. It followed 80,597 women for an average of 8.8 years, during which 1,016 developed breast cancer. Crucially, it estimated acrylamide from repeated 24-hour dietary records, an average of 5.5 per participant, which is a more precise measure than a single questionnaire.

Women in the highest quarter of intake had a borderline increase in breast cancer risk overall (HR 1.21, 1.00–1.47) and a clearer increase in premenopausal breast cancer (1.40, 1.04–1.88), concentrated in oestrogen-receptor-positive tumours. There was no association with postmenopausal breast cancer. Hogervorst and Schouten, writing alongside the paper, judged the evidence to point "in the direction of an increased risk for certain gynaecological cancers" while calling the field overall "still cloudy, even after 20 years of research".

Two details deserve stating. The authors report that the association was not orderly: risk was elevated at both the second and the fourth quarters of intake, which is not the pattern you expect if more exposure means more risk. And the main contributors to acrylamide intake in that cohort were coffee, chips and crisps, pastries, cakes and bread. Not one of those is a burnt food. They are ordinary foods, cooked normally, which is where most dietary acrylamide comes from.

The biomarker findings that complicate everything

A German study published in Archives of Toxicology in 2024 took a different approach, measuring acrylamide directly in blood and urine rather than estimating it from diet. It compared 36 omnivores, 36 vegans and 16 strict raw-food eaters who had eaten nothing heated above 42°C for at least four months. Haemoglobin adducts, a marker reflecting exposure over the lifespan of a red blood cell, came out at a median 27.7 picomoles per gram in non-smoking omnivores and 39.7 in vegans.

Vegans, in other words, carried roughly 40% more acrylamide than meat eaters. The authors attribute this to the food groups a plant-based diet leans on, since bread, coffee and potato products supply most dietary acrylamide and a narrower range of meals may concentrate them. It is a useful corrective to the idea that acrylamide is a meat-and-frying problem.

The raw-food eaters were the real surprise. Having eaten nothing heated for four months, they still carried a median 13.3 picomoles per gram, about 48% of the omnivore level. Converted to an equivalent external dose, that is roughly 0.22 micrograms per kilogram of body weight a day, against EFSA's estimate of 0.4 for average dietary intake. The authors conclude that the body forms acrylamide internally at a scale "distinctly higher than reported previously".

The authors are careful about this, and so should anyone citing them be. They devote a section to other possible sources and call the word "endogenous" a simplification. Skin exposure from hair and personal care products is theoretically possible but poorly evidenced and poorly absorbed. Inhaled exposure from second-hand smoke, barbecues and campfires is plausible, though all 16 participants denied it. And their food may have contained acrylamide without high-heat cooking at all: dried dates, apricots and plums have been measured at up to 141 micrograms per kilogram, formed during drying. The residual exposure is substantially internal, but not provably all of it.

Charred meat is a separate question

Acrylamide forms in starchy foods. The compounds that form on blackened meat are different ones — heterocyclic amines and polycyclic aromatic hydrocarbons, produced when muscle protein meets high heat and when fat drips onto a flame. The evidence base here is much stronger than the one for acrylamide, which makes it worth being precise about what it covers.

The largest prospective synthesis, published in 2021, pooled 148 articles. High red meat consumption was associated with higher risk of colorectal cancer (1.10, 1.03–1.17), colon cancer (1.17, 1.09–1.25), breast cancer (1.09, 1.03–1.15) and lung cancer (1.26, 1.09–1.44), while processed meat carried an 18% higher colorectal and 21% higher colon cancer risk. These are consistent, replicated associations, and they are the basis for the standard advice to limit red and processed meat.

But the comparison in every one of those analyses is between people who ate the most meat and people who ate the least. It is a question about quantity rather than temperature, and the pooled estimates are not broken down by cooking method. The same gap appears in a 2025 meta-analysis of 60 prospective studies, which reproduces the colorectal findings and contains no analysis of doneness. Whether charring your steak adds risk beyond eating the steak is not something the large syntheses answer.

What This Actually Means

Two opposite errors are easy to make here. The first is treating null findings as an all-clear: a million people studied with a blunt measure of exposure is not the same as a million people studied well, and an association could exist and be missed. The second is treating imperfect measurement as grounds for assuming a large hidden risk. Poor exposure data widens the uncertainty in both directions; it does not supply evidence of harm.

What survives both errors is modest and reasonably clear. Acrylamide is genotoxic in animals, which is why EFSA's margin of exposure comes out at 300 for the average adult and 120 for toddlers against a threshold of 10,000 for low concern, and why food manufacturers are legally required to manage its formation. In humans the signal is at most weak and confined to hormone-driven cancers in women, and the exposure is less controllable than people assume, since about half of what shows up in your blood would be there whether you ate anything browned or not.

So reducing browning is a cheap precaution rather than an intervention worth anxiety. The Food Standards Agency advises aiming for a golden yellow colour or lighter when frying, baking, toasting or roasting starchy foods, following pack instructions on chips and roast potatoes, and eating a balanced diet with five portions of fruit and vegetables a day. One piece of that advice has gone: after a study reviewed by the Committee on Toxicity, the FSA now says fridge storage of raw potatoes "doesn't materially increase acrylamide forming potential".

Frequently Asked Questions

Is burnt toast bad for you?

Darker toast contains more acrylamide than lighter toast, and the FSA advises aiming for golden yellow or lighter across toast, chips and roast potatoes alike. No human study has compared people by how brown their toast was, so no cancer risk has been measured for a particular shade, and no human evidence supports giving these foods up.

Does scraping the burnt bits off help?

It removes the part with the highest concentration, so it reduces your intake a little, but it is not a cancer intervention. The 2024 biomarker work suggests roughly half the acrylamide circulating in a typical person would be there regardless of diet, and most of the dietary half comes from normally cooked foods.

Is it still bad to keep potatoes in the fridge?

No, that advice was withdrawn. A study reviewed by the Committee on Toxicity found fridge storage does not materially increase acrylamide-forming potential compared with a cool dark place, and the FSA now says either is fine.

Does barbecued or charred meat cause cancer?

Red and processed meat are consistently associated with higher colorectal and several other cancer risks across 148 prospective studies. Those analyses compare how much meat people ate, not how it was cooked, so the specific contribution of charring has not been quantified. Limiting red and processed meat has better evidence behind it than avoiding char.

Which foods contribute the most acrylamide?

In the French cohort, the leading contributors were coffee, potato chips and crisps, pastries, cakes and bread. The FSA's list also includes roasted root vegetables, biscuits and breakfast cereals. Dried fruit can contain it too, formed during drying rather than cooking.

The Bottom Line

Burnt food contains a probable carcinogen, and cutting down on browning is a sensible, no-cost precaution that regulators across Europe recommend. What the research does not show is a measured cancer risk from burning food, and it cannot, because the large studies estimated acrylamide intake from questionnaires and never recorded how dark anything was. Add the 2024 finding that vegans carry more acrylamide than omnivores, and that people eating nothing heated still carry half the usual amount, and what emerges is a compound worth reducing at industrial scale rather than at the breakfast table. Aim for golden rather than dark, and spend the worry elsewhere.

This article is for general information and is not medical advice. If you have any concern about your diet or your cancer risk, speak to your GP.

Sources

• Filippini T, et al. Dietary Acrylamide Exposure and Risk of Site-Specific Cancer: A Systematic Review and Dose-Response Meta-Analysis of Epidemiological Studies. Frontiers in Nutrition, 2022. https://pubmed.ncbi.nlm.nih.gov/35548558/
• Monien BH, et al. Internal exposure to heat-induced food contaminants in omnivores, vegans and strict raw food eaters: biomarkers of exposure to acrylamide and new insights on its endogenous formation. Archives of Toxicology, 2024. https://pubmed.ncbi.nlm.nih.gov/38819476/
• Bellicha A, et al. Dietary exposure to acrylamide and breast cancer risk: results from the NutriNet-Santé cohort. American Journal of Clinical Nutrition, 2022. https://pubmed.ncbi.nlm.nih.gov/36055962/
• Adani G, et al. Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis. Cancer Epidemiology, Biomarkers & Prevention, 2020. https://pubmed.ncbi.nlm.nih.gov/32169997/
• Farvid MS, et al. Consumption of red meat and processed meat and cancer incidence: a systematic review and meta-analysis of prospective studies. European Journal of Epidemiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34455534/
• Hogervorst JGF, Schouten LJ. Dietary acrylamide and human cancer; even after 20 years of research an open question. American Journal of Clinical Nutrition, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9535542/
• Food Standards Agency. Acrylamide. Current guidance. https://www.gov.uk/government/publications/acrylamide/acrylamide
• IARC Monographs. Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024. https://monographs.iarc.who.int/wp-content/uploads/2019/10/IARCMonographs-AGReport-Priorities_2020-2024.pdf
• IARC Monographs. Advisory Group recommendations on priorities for the IARC Monographs during 2025–2029. https://monographs.iarc.who.int/news-events/advisory-group-recommendations-on-priorities-for-the-iarc-monographs/
• Ungvari Z, et al. Association between red and processed meat consumption and colorectal cancer risk: a comprehensive meta-analysis of prospective studies. GeroScience, 2025. https://pubmed.ncbi.nlm.nih.gov/40210826/